Vasopro Ephedrine
NDC Package 70258-320-24

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Vasopro Ephedrine is uses: • Temporarily relieves shortness of breath, tightness of chest, and wheezing due to bronchial asthma • Eases breathing for asthma patients • Helps loosen mucus and thin bronchial secretions to drain bronchial tubes. Marketed by Optimal Research Inc, this product is identified by NDC 70258-320 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
70258-320-24
Package Description
1 BLISTER PACK in 1 BOX / 24 TABLET in 1 BLISTER PACK
Product Code
70258-320
11-Digit Billing Format
70258032024
RxNorm Crosswalk
  • RxCUI: 1116145 - ePHEDrine HCl 25 MG / guaiFENesin 200 MG Oral Tablet
  • RxCUI: 1116145 - ephedrine hydrochloride 25 MG / guaifenesin 200 MG Oral Tablet

Clinical Specifications

Proprietary Name
Vasopro Ephedrine
Dosage Form
-
Usage Information
Uses: • Temporarily relieves shortness of breath, tightness of chest, and wheezing due to bronchial asthma • Eases breathing for asthma patients • Helps loosen mucus and thin bronchial secretions to drain bronchial tubes.

Regulatory & Marketing

Labeler Name
Optimal Research Inc
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
11-23-2015
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70258-320-24 identifies a specific commercial package of 1 blister pack in 1 box / 24 tablet in 1 blister pack of Vasopro Ephedrine, labeled by Optimal Research Inc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Optimal Research Inc on November 23, 2015. The current certification is valid through December 31, 2017.

How is this Optimal Research Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70258032024. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70258-320-24
11-Digit CMS (5-4-2)
70258-0320-24

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.